(Q37740701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Genetic aberrations in paediatric acute leukaemias and implications for management of patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Christine J Harrison

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jacques Van Dongen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jacques J M van Dongen

series ordinal

3

object named as

Jacques J M van Dongen

1 reference

22 August 2017

Christine J Harrison

2

1 reference

22 August 2017

7 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

880-889

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20435517%20AND%20SRC:MED&resulttype=core&format=json

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Oncogenic transcription factors in the human acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Origins of chromosome translocations in childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10 and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemi

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

JAK mutations in high-risk childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

The impact of NOTCH1, FBW7 and PTEN mutations on prognosis and downstream signaling in pediatric T-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

The role of FLT3 in haematopoietic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Minimal residual disease in leukaemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leu

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

New insights to the MLL recombinome of acute leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Pediatric acute myeloid leukemia: international progress and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

Philadelphia positive acute lymphoblastic leukaemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970369-9

7 January 2021